Covered recipient · General Payments record
CHRISTOPHER ANGELO SEQUEIRA
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$3,790.84
- Reported across 204 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,174.06 | 58 |
| Education | $74.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $137.59 | 6 |
| Gilead Sciences, Inc. | $116.12 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $90.71 | 5 |
| Janssen Biotech, Inc. | $90.02 | 2 |
| PFIZER INC. | $85.23 | 4 |
| Acerta Pharma LLC | $62.63 | 2 |
| Genentech USA, Inc. | $61.42 | 3 |
| Astellas Pharma US Inc | $60.48 | 3 |
| JAZZ PHARMACEUTICALS INC. | $60.17 | 3 |
| Incyte Corporation | $50.55 | 3 |
| ABBVIE INC. | $45.64 | 2 |
| BeiGene USA, Inc. | $43.64 | 3 |
| Daiichi Sankyo Inc. | $38.88 | 2 |
| Sumitomo Pharma America, Inc. | $37.48 | 2 |
| GlaxoSmithKline, LLC. | $33.80 | 2 |
| Merck Sharp & Dohme Corporation | $33.19 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.46 | 1 |
| Napo Pharmaceuticals Inc | $26.64 | 1 |
| Lilly USA, LLC | $23.28 | 1 |
| TerSera Therapeutics LLC | $21.77 | 1 |
| Agios Pharmaceuticals, Inc. | $20.75 | 1 |
| ARRAY BIOPHARMA INC | $19.50 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.18 | 1 |
| GENZYME CORPORATION | $15.84 | 1 |
| SERVIER PHARMACEUTICALS LLC | $14.78 | 1 |
| ADC Therapeutics America, Inc. | $14.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (59)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.